These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1714285)

  • 1. Isolation, identification, and assay of [3H]-porfiromycin adducts of EMT6 mouse mammary tumor cell DNA: effects of hypoxia and dicumarol on adduct patterns.
    Tomasz M; Hughes CS; Chowdary D; Keyes SR; Lipman R; Sartorelli AC; Rockwell S
    Cancer Commun; 1991 Jul; 3(7):213-23. PubMed ID: 1714285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adducts of mitomycin C and DNA in EMT6 mouse mammary tumor cells: effects of hypoxia and dicumarol on adduct patterns.
    Bizanek R; Chowdary D; Arai H; Kasai M; Hughes CS; Sartorelli AC; Rockwell S; Tomasz M
    Cancer Res; 1993 Nov; 53(21):5127-34. PubMed ID: 7693331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mechanism of the cytotoxic action of the mitomycin antibiotics in hypoxic and oxygenated EMT6 cells.
    Sartorelli AC; Tomasz M; Rockwell S
    Adv Enzyme Regul; 1993; 33():3-17. PubMed ID: 8356915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of a major DNA adduct of the mitomycin metabolite 2,7-diaminomitosene in EMT6 mouse mammary tumor cells treated with mitomycin C.
    Palom Y; Belcourt MF; Kumar GS; Arai H; Kasai M; Sartorelli AC; Rockwell S; Tomasz M
    Oncol Res; 1998; 10(10):509-21. PubMed ID: 10338154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of the metabolism and cytotoxicity of bioreductive alkylating agents by dicoumarol in aerobic and hypoxic murine tumor cells.
    Keyes SR; Rockwell S; Sartorelli AC
    Cancer Res; 1989 Jun; 49(12):3310-3. PubMed ID: 2470504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioreductive metabolism of mitomycin C in EMT6 mouse mammary tumor cells: cytotoxic and non-cytotoxic pathways, leading to different types of DNA adducts. The effect of dicumarol.
    Palom Y; Belcourt MF; Tang LQ; Mehta SS; Sartorelli AC; Pritsos CA; Pritsos KL; Rockwell S; Tomasz M
    Biochem Pharmacol; 2001 Jun; 61(12):1517-29. PubMed ID: 11377381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the cytotoxicity of porfiromycin by dicoumarol in vitro and in vivo.
    Rockwell S; Keyes SR; Sartorelli AC
    Anticancer Res; 1989; 9(4):817-20. PubMed ID: 2479329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid chromatography-thermospray mass spectrometry of DNA adducts formed with mitomycin C, porfiromycin and thiotepa.
    Musser SM; Pan SS; Callery PS
    J Chromatogr; 1989 Jul; 474(1):197-207. PubMed ID: 2504760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative toxicities of DNA cross-links and monoadducts: new insights from studies of decarbamoyl mitomycin C and mitomycin C.
    Palom Y; Suresh Kumar G; Tang LQ; Paz MM; Musser SM; Rockwell S; Tomasz M
    Chem Res Toxicol; 2002 Nov; 15(11):1398-406. PubMed ID: 12437330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pH on DNA alkylation by enzyme-activated mitomycin C and porfiromycin.
    Yu F; Pan SS
    Mol Pharmacol; 1993 Jun; 43(6):863-9. PubMed ID: 8391116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between drug uptake and selective toxicity of porfiromycin to hypoxic EMT6 cells.
    Keyes SR; Rockwell S; Sartorelli AC
    Cancer Res; 1987 Nov; 47(21):5654-7. PubMed ID: 3664473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolites and DNA adduct formation from flavoenzyme-activated porfiromycin.
    Pan SS; Iracki T
    Mol Pharmacol; 1988 Aug; 34(2):223-8. PubMed ID: 3412325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of adduct X, the last unknown of the six major DNA adducts of mitomycin C formed in EMT6 mouse mammary tumor cells.
    Palom Y; Belcourt MF; Musser SM; Sartorelli AC; Rockwell S; Tomasz M
    Chem Res Toxicol; 2000 Jun; 13(6):479-88. PubMed ID: 10858321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping DNA adducts of mitomycin C and decarbamoyl mitomycin C in cell lines using liquid chromatography/ electrospray tandem mass spectrometry.
    Paz MM; Ladwa S; Champeil E; Liu Y; Rockwell S; Boamah EK; Bargonetti J; Callahan J; Roach J; Tomasz M
    Chem Res Toxicol; 2008 Dec; 21(12):2370-8. PubMed ID: 19053323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of C-7 substituted cyclic acetal derivatives of mitomycin C and porfiromycin against hypoxic and oxygenated EMT6 carcinoma cells in vitro and in vivo.
    Rockwell S; Keyes SR; Loomis R; Kelley M; Vyas DM; Wong H; Doyle TW; Sartorelli AC
    Cancer Commun; 1991 Jun; 3(6):191-8. PubMed ID: 2049227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porfiromycin disposition in oxygen-modulated P388 cells.
    Pan SS
    Cancer Chemother Pharmacol; 1990; 27(3):187-93. PubMed ID: 2265454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical studies of porfiromycin as an adjunct to radiotherapy.
    Rockwell S; Keyes SR; Sartorelli AC
    Radiat Res; 1988 Oct; 116(1):100-13. PubMed ID: 3186923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mitomycin-N6-deoxyadenosine adduct isolated from DNA.
    Palom Y; Lipman R; Musser SM; Tomasz M
    Chem Res Toxicol; 1998 Mar; 11(3):203-10. PubMed ID: 9544618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of adducts derived from reactions of (1-chloroethenyl)oxirane with nucleosides and calf thymus DNA.
    Munter T; Cottrell L; Hill S; Kronberg L; Watson WP; Golding BT
    Chem Res Toxicol; 2002 Dec; 15(12):1549-60. PubMed ID: 12482237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity and DNA lesions produced by mitomycin C and porfiromycin in hypoxic and aerobic EMT6 and Chinese hamster ovary cells.
    Fracasso PM; Sartorelli AC
    Cancer Res; 1986 Aug; 46(8):3939-44. PubMed ID: 3089583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.